CHEMET
What it isOral dithiol chelator for lead poisoning in children with blood lead levels above 45 mcg/dL.
Why this oneAllows outpatient oral chelation for moderate lead poisoning and causes less essential-metal loss than calcium disodium EDTA.
What limits itIt does not cross the blood-brain barrier or treat lead encephalopathy; remove the exposure source and monitor for rebound lead levels, neutropenia, and transaminitis.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Lead poisoning | Pediatric | 10 mg/kg or 350 mg/m² q8h (TID) ×5 days | then 10 mg/kg or 350 mg/m² q12h (BID) ×14 days |
Renal Assess renal function (BUN/creatinine/urinary protein) before treatment; succimer and lead are renally excreted.
Hepatic Monitor AST/ALT at baseline and weekly; reduce/interrupt if elevations >5× ULN.
Total 19-day course; minimum 2 weeks between repeat courses; dosing >3 weeks not established.
Pregnancy May cause fetal harm (animal data); use only if benefit justifies risk; use contraception during and 14 days after.
Lactation No data on presence in milk; women with blood lead ≥40 mcg/dL should not breastfeed.
NO BOXED WARNINGS
Principal riskneutropenia; monitor CBC and interrupt if ANC falls below 1,200/mcL
Cost, est. cash$50–$3,000/use
Generic entryNo US generic
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityAllergic, renal or procedure-related complications vary by diagnostic agent and route.
